The Effectiveness and Safety of HIIT in Overweight Male Subjects

Sponsor
Indonesia University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05000437
Collaborator
(none)
16
2
1
22.9
8
0.3

Study Details

Study Description

Brief Summary

Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.

Condition or Disease Intervention/Treatment Phase
  • Other: HIIT
N/A

Detailed Description

  • Subjects are recruited via e-flyer distributed online across university departments. Individual who is interested in study participation fills out screening form. Research assistants screen subjects eligibility. Subjects are coded based on the order of screening form fulfillment.

  • Research assistants are using the standard operational procedures for each assessments. Training for the research assistants precedes the data collection to ensure the similarity of understanding and skills during measurements. One research assistant responsible for scheduling the assessments and training sessions. Continuous evaluation are planned weekly to provide room for improvements in the process of data collection.

  • Sample size assessment is measured from 5 primary output by a research assistants using sample size calculation website for single intervention clinical trial.

  • Investigator use paper based data collection for each assessment and during training sessions. Subject are encouraged to report any symptoms and signs during intervention period in each meeting with the research assistants or via online messaging. Any reports will be documented in separated form. One research assistant makes sure the data fields are completed in each measurements and during training sessions. The assistant also check the similarity of the data entered in the master table.

  • Data analysis will be lead by one research assistant using newest version of SPSS software. The analysis will be started after the baseline measurement is completed although the data collection is not finished. All numeric data will be presented as mean and standard deviations if normally distributed or median and minimum maximum range if not normally distributed. Paired t-test will be used to identify the difference before and after the intervention if the data are normally distributed. If the data are not normally distributed, Wilcoxon test will be used to identify the difference before and after the intervention.

To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects
Actual Study Start Date :
Nov 1, 2020
Actual Primary Completion Date :
Oct 30, 2021
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: High Intensity Interval Training

single arm intervention, with high intensity interval training

Other: HIIT
3x/week high intensity interval training for 12 weeks

Outcome Measures

Primary Outcome Measures

  1. cardiorespiratory fitness [12 weeks]

    VO2Max in ml/kg/minute

  2. body mass index [week 4]

    weight and height combined as BMI in kg/m2

  3. body mass index [week 8]

    weight and height combined as BMI in kg/m2

  4. body mass index [week 12]

    weight and height combined as BMI in kg/m2

  5. body fat mass [week 4]

    total fat mass in the body as percentage

  6. body fat mass [week 8]

    total fat mass in the body as percentage

  7. body fat mass [week 12]

    total fat mass in the body as percentage

  8. visceral fat [week 4]

    body fat stored within abdominal cavity as ratings

  9. visceral fat [week 8]

    body fat stored within abdominal cavity as ratings

  10. visceral fat [week 12]

    body fat stored within abdominal cavity as ratings

  11. waist circumference [week 4]

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

  12. waist circumference [week 8]

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

  13. waist circumference [week 12]

    circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm

  14. lipid profile [12 weeks]

    total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride

  15. antioxidant level [12 weeks]

    SOD in U/mg

  16. free radicals level [12 weeks]

    MDA in nmol/mg

  17. inflammation [12 weeks]

    TNF-alpha in microgram/ml

  18. interleukin level [12 weeks]

    IL-6 nanogram/ml

Secondary Outcome Measures

  1. Fat Burning Effect [week 1, 6, 12]

    FGF21

  2. Myokin [week 1, 6, 12]

    Irisin

  3. Cognitive Function Screening [week 1 and 12]

    Montreal Cognitive Assessment as score

  4. Working memory Capacity [week 1 and 12]

    N-Back test as percentage of correct answers

  5. Executive Function [week 1 and 12]

    Trail Making Test A and B as seconds

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • overweight (BMI 25 - 29,9)

  • live in Jakarta and greater area

  • willing to participate

Exclusion Criteria:
  • smoking

  • any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fakultas Kedokteran Universitas Indonesia Jakarta Pusat DKI Jakarta Indonesia 10430
2 Universitas Indonesia Jakarta Pusat DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: Nani Sudarsono, Fakultas Kedokteran Universitas Indonesia

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Nani Cahyani Sudarsono, Head of Sports Medicine Study Program, Indonesia University
ClinicalTrials.gov Identifier:
NCT05000437
Other Study ID Numbers:
  • 20-09-1081
First Posted:
Aug 11, 2021
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nani Cahyani Sudarsono, Head of Sports Medicine Study Program, Indonesia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022